Advanced Search

Study Preview



Study Title and Description

Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients.



Key Questions Addressed
3 In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients.
Author Cibrik D., Meier-Kriesche HU., Bresnahan B., Wu YM., Klintmalm G., Kew CE., Kuo PC., Whelchel J., Cohen D., Baliga P., Akalin E., Benedetti E., Wright F., Lieberman B., Ulbricht B., Jensik S.
Country Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, MI 48109, USA. dcibrik@umich.edu
Year -- Not Found --
Numbers Pubmed ID: 17425744
2036 (internal)

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Comparative Effectiveness of Regimens


Results & Comparisons

No Results found.